Skip to content

clinical trial of weight management supplementation

A Prospective exploratory clinical trial to assess safety and efficacy of WMS01 in management of weight in healthy adults. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/01/039232
Enrollment
30
Registered
2022-01-07
Start date
Unknown
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Naturedge Beverages Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Obese patients (male/female and aged between 20-45 yrs.) BMI between 30 - 40 kg/m2 Subjects with or without comorbidities, if comorbidity exists should be on stable prescription and with the following criteria- Hypertension (140/90 mmHg on prescription), Type 2 DM (HbA1C Willing to provide consent Willing for follow up

Exclusion criteria

Exclusion criteria: Subjects with any acute illness requiring immediate medical care. Subjects with Type I DM/Complicated cardiovascular diseases / HbA1C >= 7.5. / History of TIA, Cerebrovascular accident, stroke or any revascularization. Known subjects of hepatic failure/inflammation. Pregnant, breast feeding or planning to become pregnant during the study. Any other condition which proves subject unfit for the study participation

Design outcomes

Primary

MeasureTime frame
1.Changes in Body Weight 2.Changes in BMI 3.Changes in Quality of life of subjects by IWQOL-Lite score (The Impact of Weight on Quality of Life Questionnaire) in social and emotional aspect 4.Changes in Eating Disorder examination questionnaire score 5.Changes in energy audit questionnaire score Timepoint: screening , baseline and day 60

Secondary

MeasureTime frame
1.Changes in digestive behavior (Bloating, Heartburn, Flatulence, Constipation, Post Prandial Fullness etc.) in subjects 2. Changes in anthropometric parameters such as Waste/Hip Ratio, Mid upper arm Circumference, Body Fat %, Visceral Fat level % etc. 3. Changes in general complaints like profuse sweating, irregular thirst, dyspnea and uncontrolled hunger on 0-10 VAS score. 4.Changes in Lipid profile Timepoint: screening , baseline and day 60

Countries

India

Contacts

Public ContactMr Sharad Dhurde

Naturedge Beverages Pvt. Ltd.

bshrikhande@siddhayu.com9371490526

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026